PTC Therapeutics
PTCT
#2687
Rank
HK$48.26 B
Marketcap
HK$601.18
Share price
-0.76%
Change (1 day)
59.62%
Change (1 year)

PTC Therapeutics (PTCT) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : HK$21.78 Billion

According to PTC Therapeutics 's latest financial reports the company's total liabilities are HK$21.78 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

PTC Therapeutics - Total liabilities on balance sheet (from 2012 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31HK$21.76 B2.66%
2023-12-31HK$21.19 B32.17%
2022-12-31HK$16.03 B6.21%
2021-12-31HK$15.10 B12.84%
2020-12-31HK$13.38 B66.92%
2019-12-31HK$8.01 B33.22%
2018-12-31HK$6.01 B227.47%
2017-12-31HK$1.83 B58.24%
2016-12-31HK$1.16 B7.58%
2015-12-31HK$1.07 B300.49%
2014-12-31HK$0.26 B126.3%
2013-12-31HK$0.11 B-52.37%
2012-12-31HK$0.25 B-88.61%
2011-12-31HK$2.19 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Vertex Pharmaceuticals
VRTX
HK$58.70 B 169.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
HK$16.91 B-22.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
HK$0.85 B-96.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNA
HK$1.92 B-91.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
HK$1.89 B-91.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$486.64 B 2,133.90%๐Ÿ‡จ๐Ÿ‡ญ Switzerland